Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Inhibitor Therapeutics, Inc. per 2025 Jun 30 adalah -3.67 MM.
- Nilai net income untuk Inhibitor Therapeutics, Inc. per 2025 Jun 30 adalah -3.45 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -3.67 | -3.45 | |
2025-03-31 | -3.56 | -3.29 | |
2024-12-31 | -3.66 | -3.34 | |
2024-09-30 | -3.45 | -3.08 | |
2024-06-30 | -3.39 | -3.02 | |
2024-03-31 | -3.55 | -3.17 | |
2023-12-31 | -3.40 | -3.03 | |
2023-09-30 | -2.56 | 10.50 | |
2023-06-30 | -1.87 | 11.09 | |
2023-03-31 | -1.19 | 11.67 | |
2022-12-31 | -0.66 | 12.11 | |
2022-09-30 | -0.26 | -0.29 | |
2022-06-30 | -0.26 | -0.28 | |
2022-03-31 | -0.25 | -0.27 | |
2021-12-31 | -0.33 | -0.30 | |
2021-09-30 | -0.35 | -0.32 | |
2021-06-30 | -0.59 | -0.55 | |
2021-03-31 | -0.84 | -0.80 | |
2020-12-31 | -1.06 | -1.06 | |
2020-09-30 | -1.64 | -1.64 | |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -0.02 | -0.02 |
2024-12-31 | -0.02 | |
2024-09-30 | -0.02 | -0.02 |
2024-06-30 | -0.02 | -0.02 |
2024-03-31 | -0.02 | -0.02 |
2023-12-31 | -0.02 | |
2023-09-30 | 0.05 | 0.04 |
2023-06-30 | 0.04 | 0.04 |
2023-03-31 | 0.04 | 0.03 |
2022-12-31 | 0.03 | 0.03 |
2022-09-30 | -0.00 | -0.00 |
2022-06-30 | -0.00 | -0.00 |
2022-03-31 | -0.00 | -0.00 |
2021-12-31 | -0.00 | -0.00 |
2021-09-30 | -0.00 | -0.00 |
2021-06-30 | -0.00 | -0.00 |
2021-03-31 | -0.00 | -0.00 |
2020-12-31 | -0.00 | -0.00 |
2020-09-30 | -0.00 | -0.00 |
2020-06-30 | -0.01 | -0.01 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Inhibitor Therapeutics, Inc. per 2025 Jun 30 adalah -3.36 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -3.36 | ||
2025-03-31 | -3.36 | ||
2024-12-31 | -3.23 | ||
2024-09-30 | -3.16 | 0.00 | |
2024-06-30 | -3.00 | 0.00 | |
2024-03-31 | -3.10 | 0.00 | |
2023-12-31 | -2.70 | -0.41 | |
2023-09-30 | 9.90 | -0.41 | |
2023-06-30 | 10.41 | -0.33 | |
2023-03-31 | 11.03 | -0.28 | |
2022-12-31 | 11.74 | 0.18 | |
2022-09-30 | -0.18 | 0.18 | |
2022-06-30 | -0.17 | 0.10 | |
2022-03-31 | -0.17 | 0.12 | |
2021-12-31 | -0.22 | 0.18 | |
2021-09-30 | -0.21 | 0.23 | |
2021-06-30 | -0.27 | 0.23 | |
2021-03-31 | -0.42 | 0.20 | |
2020-12-31 | -0.83 | 0.10 | |
2020-09-30 | -1.38 | 0.04 | |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/libro untuk Inhibitor Therapeutics, Inc. pada 2025 Jun 30 adalah 8.92.
- p/tbv untuk Inhibitor Therapeutics, Inc. pada 2025 Jun 30 adalah 8.92.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | 8.92 | 8.92 | |
2025-03-31 | 6.08 | 6.08 | |
2024-12-31 | 3.54 | 3.54 | |
2024-09-30 | -4.00 | 2.92 | 2.92 |
2024-06-30 | -3.80 | 2.60 | 2.60 |
2024-03-31 | 1.83 | 1.83 | |
2023-12-31 | 1.97 | 3.20 | |
2023-09-30 | 0.56 | 0.87 | 0.87 |
2023-06-30 | 0.54 | 0.82 | 0.82 |
2023-03-31 | -63.92 | -4.57 | |
2022-12-31 | -4.57 | -4.57 | |
2022-09-30 | -4.98 | -4.98 | |
2022-06-30 | -139.73 | -10.00 | -10.00 |
2022-03-31 | -164.68 | -13.58 | -13.58 |
2021-12-31 | -175.79 | -15.95 | -15.95 |
2021-09-30 | -102.49 | -16.12 | -16.12 |
2021-06-30 | |||
2021-03-31 | -53.89 | -12.71 | -12.71 |
2020-12-31 | -40.58 | -12.78 | -12.78 |
2020-09-30 | -26.21 | -12.73 | -12.73 |
2020-06-30 | -21.14 | -13.01 | -13.01 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Inhibitor Therapeutics, Inc. pada 2025 Jun 30 adalah -0.42.
- EBIT (3 tahun) / EV untuk Inhibitor Therapeutics, Inc. pada 2025 Jun 30 adalah 0.21.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.42 | 0.21 |
2025-03-31 | -0.52 | 0.27 |
2024-12-31 | -0.54 | 0.35 |
2024-09-30 | -0.61 | 0.49 |
2024-06-30 | -0.72 | 0.63 |
2024-03-31 | 4.66 | 3.30 |
2023-12-31 | 0.95 | 0.30 |
2023-09-30 | -2.85 | -0.88 |
2023-06-30 | -2.91 | -0.90 |
2023-03-31 | -0.01 | -0.02 |
2022-12-31 | -0.01 | -0.03 |
2022-09-30 | -0.01 | -0.03 |
2022-06-30 | -0.01 | -0.02 |
2022-03-31 | -0.01 | -0.02 |
2021-12-31 | -0.01 | -0.02 |
2021-09-30 | -0.01 | -0.03 |
2021-06-30 | ||
2021-03-31 | -0.02 | -0.05 |
2020-12-31 | -0.02 | -0.06 |
2020-09-30 | -0.03 | -0.07 |
2020-06-30 | -0.04 | -0.07 |
Efektivitas Manajemen
- roa untuk Inhibitor Therapeutics, Inc. pada 2025 Jun 30 adalah -0.46.
- roe untuk Inhibitor Therapeutics, Inc. pada 2025 Jun 30 adalah -0.79.
- roic untuk Inhibitor Therapeutics, Inc. pada 2025 Jun 30 adalah -2.29.
- croic untuk Inhibitor Therapeutics, Inc. pada 2025 Jun 30 adalah -2.34.
- ocroic untuk Inhibitor Therapeutics, Inc. pada 2025 Jun 30 adalah -2.34.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.46 | -0.79 | -2.29 | -2.34 | -2.34 |
2025-03-31 | -0.43 | -0.72 | -1.68 | -1.63 | -1.63 |
2024-12-31 | -0.34 | -0.58 | -0.91 | -0.93 | -0.93 |
2024-09-30 | -0.31 | -0.47 | -0.73 | -0.73 | -0.73 |
2024-06-30 | -0.29 | -0.41 | -0.68 | -0.67 | -0.67 |
2024-03-31 | 0.88 | 1.27 | 1.63 | 1.47 | 1.53 |
2023-12-31 | 166.38 | 1.63 | 1.47 | 1.53 | |
2023-09-30 | 287.89 | 1.56 | 1.42 | 1.46 | |
2023-06-30 | 302.87 | 1.47 | 1.34 | 1.38 | |
2023-03-31 | -4.71 | 1.43 | 1.32 | ||
2022-12-31 | -3.11 | ||||
2022-09-30 | -3.04 | ||||
2022-06-30 | -1.98 | ||||
2022-03-31 | -2.16 | ||||
2021-12-31 | -2.44 | ||||
2021-09-30 | -3.09 | ||||
2021-06-30 | -2.55 | ||||
2021-03-31 | -2.02 | ||||
2020-12-31 | -1.18 | ||||
2020-09-30 | -1.10 | ||||
2020-06-30 | -0.94 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1042418 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |